An interview with Asst Prof Tim Xu and A/P Wee Shiou Liang from Health and Social Sciences, SIT, on helping the elder live safer and easier lives.
Harnessing Technology to Enable Hope for GBM: Tumour Treating Fields By Dr Daniel Tan In October 2015, the U.S. Food and Drug Administration (FDA) approved the use of a new treatment called Tumour Treating Fields (TTF) in combination with temozolomide chemotherapy for the treatment of newly diagnosed GBM.
By Hema Thiagarajah A rapidly ageing population, combined with a surge in chronic, non-communicable diseases is driving the rise of healthcare costs in Asia. Digital therapeutics holds immense potential to radically transform healthcare from reactive treatment to proactive, predictive prevention and management of disease.
A cross-disciplinary research from the Chinese Academy of Sciences (CAS) has discovered a novel natural product derivative with anti-hypertrophic effects...
Researchers from Duke-NUS Medical School and Monash University have uncovered the mechanism behind microglial phagocytosis of amyloid proteins, one of the root causes of Alzheimer’s disease.
